Big Pharma Lashes Out At Generic Competition

Law360, New York (June 29, 2006, 12:00 AM EDT) -- Brand-name drug manufacturers, facing potentially billions of dollars in losses when their patent protection on drugs expires, are attempting to protect their market shares by slashing prices to undercut the generic competition--a move that has some accusing the pharmaceutical companies of predatory pricing.

Just one week after Merck & Co. offered to sell cholesterol drug Zocor to insurance providers at a lower price than Teva Pharmaceuticals’ generic version, Pfizer Inc. said Thursday it plans to introduce a heavily discounted copycat version of antidepressant Zoloft.

Teva had...
To view the full article, register now.